Jana Maluskova

Jana Maluskova

Auto-generated profile, based on publicly available information

Jana Maluskova

Department of Cardiology, Institute for Clinical and Experimental Medicine—IKEM , Videnska 1958/9, 140 21, Prague 4

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
RCRoman Chmel
Roman Chmel
MNMarta Novackova
Marta Novackova
LJLibor Janousek
Libor Janousek
JMJan Matecha
Jan Matecha
ZPZlatko Pastor
Zlatko Pastor
JFJiri Fronek
Jiri Fronek
While uterus transplantation is still in the experimental stage, it has promising potential as a treatment for women with absolute uterine factor infertility based on the childbirths from living donor trials conducted in Sweden and the United States. We report the main characteristics and perioperative and postoperative courses of both recipients and donors following four deceased donor and five living donor uterus transplantations. Three main priorities differentiate this study from the previously reported uterus transplantations. First, clinical experience with the largest worldwide group of deceased donor uterine transplants is described. Second, in the majority of living donor uterine recipients, only two ovarian veins were used for venous blood outflow. All these recipient procedures were surgically successful, and follow‐up posttransplant ultrasound examinations revealed normal uterine blood supply and outflow. Third, in only one living and one deceased donor recipient, the transplanted uterus relied on only two uterine veins for venous outflow with a 50% surgical success rate. In all other recipients, two uterine and two ovarian veins were utilized. Although a successful pregnancy has not yet been achieved, the presented surgical and functional results of our trial are promising.

1 May 2019 in Transplantation
Verified
Journal Article
Open access
PHPetra Hruba
Petra Hruba
ZKZdenek Krejcik
Zdenek Krejcik
VSViktor Stranecky
Viktor Stranecky
JMJana Maluskova
Jana Maluskova
JSJanka Slatinska
Janka Slatinska
OVOndrej Viklicky
Ondrej Viklicky
Accommodation in AB0-incompatible (AB0i) transplantation and subclinical antibody-mediated rejection in HLA-incompatible (HLAi) transplantation share several morphological similarities. Because the clinical long-term outcomes differ, we hypothesized different molecular processes involved in AB0i transplantation and subclinical antibody-mediated rejection. Using Illumina Human HT-12 v4 Expression BeadChips, the whole transcriptome was evaluated based on 3-month protocol C4d+ biopsies in otherwise stable AB0i and HLAi kidney grafts as well as in C4d-negative HLA-compatible grafts exhibiting normal histological findings. Top differently regulated genes were further validated using RT-qPCR in another patient cohort and complement regulatory proteins by immunohistochemistry. In the case of genes involved in immune response-related biological processes, AB0i and HLAi cohorts had similar transcriptomic profiles to C4d-negative controls. The majority of deregulated genes in the AB0i and HLAi groups consisted of metallothioneins and epithelial transporter genes. Increased expression of epithelial transporters (SLC4A1; SLC4A9; SLC17A3; SLC12A3; SLC30A2) and class 1 metallothioneins (MT1F, MT1G and MT1X) in HLAi transplantation was validated by RT-qPCR. In comparison to controls, both incompatible cohorts were characterized by the upregulation of intrarenal complement regulatory genes. CD46 and CD59 transcripts were increased in the AB0i cohort while CD46 solely in HLAi group, CD59 protein expression was similar in both incompatible groups. In conclusion, several epithelial transporters and metallothioneins discriminate subclinical antibody-mediated rejection in HLAi transplantation from accommodation in AB0i transplantation, which suggest different involved downstream mechanisms and increased risk of injury in HLAi settings. Metallothioneins with their antioxidative properties may help to attenuate the inflammation response induced by DSA binding.

18 November 2015 in Physiological Research
Verified
Journal Article
Open access
ILI. Kralova Lesna
I. Kralova Lesna
ZTZbynek Tonar
Zbynek Tonar
IMI. Malek
I. Malek
JMJ. Maluskova
J. Maluskova
LNL. Nedorost
L. Nedorost
RPRudolf Poledne
Rudolf Poledne
Interesting and stimulating data about the effect of the perivascular adipose tissue size on atherogenesis are based mainly on CT findings. We studied this topic by directly analyzing perivascular adipose tissue in explanted hearts from patients undergoing transplantation. Ninety-six consecutive patients were included, including 58 with atherosclerotic coronary heart disease (CHD) and 38 with dilation cardiomyopathy (DCMP). The area of perivascular fat, area of the coronary artery wall, and ratio of CD68-positive macrophages within the perivascular fat and within the vascular wall were quantified by immunohistochemistry. There was no significant difference in the perivascular adipose tissue size between the two groups. Nevertheless, there was a significantly higher number of macrophages in the coronary arterial wall of CHD patients. In addition, we found a close relationship between the ratio of macrophages in the arterial wall and adjacent perivascular adipose tissue in the CHD group, but not in the DCMP group. According to our data interaction between macrophages in the arterial wall and macrophages in surrounding adipose tissue could be more important mechanism of atherogenesis than the size of this tissue itself.

2 June 2020 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
IJIvana Jurcova
Ivana Jurcova
JRJan Rocek
Jan Rocek
WBWilliam Bracamonte-Baran
William Bracamonte-Baran
MZMichael Zelizko
Michael Zelizko
INIvan Netuka
Ivan Netuka
JMJiri Maly
Jiri Maly
A 19-year-old woman with no previous cardiac history was admitted to the hospital with third-degree atrioventricular block and left ventricular dysfunction. Her condition quickly deteriorated to severe biventricular failure and cardiogenic shock requiring mechanical circulatory support. An endomyocardial biopsy revealed lymphocytic myocarditis with no PCR-detectable viral genomes, with CD8 T-cell predominance and pro-inflammatory macrophage expansion shown by myocardial flow cytometry. The therapy consisted of immunosuppression (high-dose methylprednisolone) and temporary mechanical circulatory support with enhanced ability to achieve left ventricular unloading by combination of extracorporeal membrane oxygenation with Impella (ECMELLA). After 2 weeks of support, complete and sustained recovery from myocarditis was observed.

15 November 2014 in Physiological Research
Verified
Journal Article
Open access
JŽJ. Ždychová
J. Ždychová
SČS. Čejková
S. Čejková
ILI. Králová Lesná
I. Králová Lesná
AKA. Králová
A. Králová
JMJ. Malušková
J. Malušková
LKL. Kazdová
L. Kazdová
The abnormal proliferation of vascular smooth muscle cells (VSMC) is thought to play a role in the pathogenesis of atherosclerosis. Adipocytes produce several bioactive paracrine substances that can affect the growth and migration of VSMCs. Our study focuses on the direct effect of the bioactive substances in conditioned media (CM) that was obtained by incubation with primary adipocyte-derived cell lines, including cell lines derived from both preadipocytes and from more mature cells, on the proliferation rate of human aortic smooth muscle cells (HAoSMCs). We used a Luminex assay to measure the adipokine content of the CM and showed that there was a higher concentration of monocyte chemoattractant protein-1 in renal preadipocyte-CM compared with the HAoSMC control (p<0.5). The addition of both renal preadipocyte- and epicardial adipocyte- CM resulted in the elevated production of vascular endothelial growth factor compared with the control HASoSMC CM (p<0.001). The adiponectin content in renal adipocyte-CM was increased compared to all the remaining adipocyte-CM (p<0.01). Moreover, the results showed a higher proliferation rate of HAoSMCs after co-culture with epicardial adipocyte-CM compared to the HAoSMC control (p<0.05). These results suggest that bioactive substances produced by adipocytes have a stimulatory effect on the proliferation of VSMCs.